These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18568776)

  • 41. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
    Yi JM; Tsai HC; Glöckner SC; Lin S; Ohm JE; Easwaran H; James CD; Costello JF; Riggins G; Eberhart CG; Laterra J; Vescovi AL; Ahuja N; Herman JG; Schuebel KE; Baylin SB
    Cancer Res; 2008 Oct; 68(19):8094-103. PubMed ID: 18829568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneous phenotype of human glioblastoma: in vitro study.
    Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
    Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro.
    Kahlert UD; Maciaczyk D; Dai F; Claus R; Firat E; Doostkam S; Bogiel T; Carro MS; Döbrössy M; Herold-Mende C; Niedermann G; Prinz M; Nikkhah G; Maciaczyk J
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1086-99. PubMed ID: 23147506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.
    Li H; Yang BB
    Oncotarget; 2012 Dec; 3(12):1653-68. PubMed ID: 23391506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
    Wan Y; Fei XF; Wang ZM; Jiang DY; Chen HC; Yang J; Shi L; Huang Q
    Chin J Cancer; 2012 Apr; 31(4):207-14. PubMed ID: 22360855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
    Wang J; Sakariassen PØ; Tsinkalovsky O; Immervoll H; Bøe SO; Svendsen A; Prestegarden L; Røsland G; Thorsen F; Stuhr L; Molven A; Bjerkvig R; Enger PØ
    Int J Cancer; 2008 Feb; 122(4):761-8. PubMed ID: 17955491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoter hypomethylation regulates CD133 expression in human gliomas.
    Tabu K; Sasai K; Kimura T; Wang L; Aoyanagi E; Kohsaka S; Tanino M; Nishihara H; Tanaka S
    Cell Res; 2008 Oct; 18(10):1037-46. PubMed ID: 18679414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.
    He H; Nilsson CL; Emmett MR; Marshall AG; Kroes RA; Moskal JR; Ji Y; Colman H; Priebe W; Lang FF; Conrad CA
    J Proteome Res; 2010 May; 9(5):2098-108. PubMed ID: 20199106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
    Shin JH; Lee YS; Hong YK; Kang CS
    J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
    Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
    J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glioblastoma cancer stem cells--from concept to clinical application.
    Stopschinski BE; Beier CP; Beier D
    Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
    Wu N; Xiao L; Zhao X; Zhao J; Wang J; Wang F; Cao S; Lin X
    FEBS Lett; 2012 Nov; 586(21):3831-9. PubMed ID: 22999819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.